Pabista

【Product name】Farydak

[English common name]Panobinostat

[Chinese common name]Pabista

[English name]LBH-589

[Chinese other name]

[Indications] Farydak is combined with bortezomib and dexamethasone for the treatment of relapse and / or refractoryMultiple myelomaAdult patients who have received at least two treatment regimens, including bortezomib and immunomodulators.

[Usage and Dosage] 20mg orally, once a day, three times a week, two weeks off each cycle for one week.

[Storage] Do not store above 30 °C. Store in original packaging to protect it from moisture.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.

Description

name

Attention: The internal data of table “96” is corrupted!

product

Attention: The internal data of table “97” is corrupted!

product manual

Click to view Pabista English product description

Click to view Pabista Chinese product description

Product information

Click to view Pabista English product information

Click to view Pabista English product specifications